Anteris Technologies Secures Favorable ATO Tax Rulings

Anteris Technologies ( (AU:AVR) ) just unveiled an update.

Anteris Technologies announced that the Australian Taxation Office has issued favorable class rulings regarding rollover relief for shareholders and optionholders in relation to Australian capital gains tax. This development, following the implementation of Schemes of Arrangement, is significant for stakeholders as it provides tax clarity and potentially enhances shareholder value.

More about Anteris Technologies

Anteris Technologies Global Corp. is a global structural heart company focused on designing, developing, and commercializing advanced medical devices to restore healthy heart function. Originating in Australia with a strong presence in Minneapolis, USA, Anteris is known for its science-driven approach and its lead product, the DurAVR® Transcatheter Heart Valve (THV), which addresses aortic stenosis using biomimetic and anti-calcification technology.

Average Trading Volume: 3,501

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $175.7M

Learn more about AVR stock on TipRanks’ Stock Analysis page.